Ceschia, Giovanni
Claes, Donna J.
Krallman, Kelli A.
Collins, Michaela
Goldstein, Stuart L.
Article History
Received: 8 October 2024
Revised: 20 January 2025
Accepted: 13 February 2025
First Online: 7 March 2025
Competing interests
: S.L.G. reports receiving personal fees from Baxter Healthcare, BioPorto Diagnostics, Calcimedica, Fresenius, Novartis, Nuwellis, MediBeacon, Medtronic, Otsuka and SeaStar Medical. None of these entities had any input into the study or manuscript, and these relationships are not relevant to the manuscript. No other disclosures were reported.
: Written parental caregiver/patient informed consent and assent were obtained prior to enrollment in the study.